Adrenomedullin causes coronary vasodilation in humans: Effects of inhibition of nitric oxide synthesis

Journal of Cardiovascular Pharmacology

Volumn 46, Issue 4, 2005, Pages 534-539

  Ueda, Kentaro ^a   Teragawa, Hiroki ^a   Kimura, Masashi ^a   Matsuda, Keiji ^a   Higashi, Yukihito ^a   Yamagata, Togo ^a   Oshima, Tetsuya ^a   Yoshizumi, Masao ^a   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Adrenomedullin; Coronary artery; Coronary blood flow; Nitric oxide

Indexed keywords

ADRENOMEDULLIN; GLYCERYL TRINITRATE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DOPPLER FLOWMETRY; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; HUMAN; INTRACORONARY INFUSION; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; SYNTHESIS; VASCULAR ENDOTHELIUM;

ADRENOMEDULLIN; AGED; ANGINA PECTORIS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PEPTIDES; VASODILATION; VASODILATOR AGENTS;

EID: 26044448572     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000179156.51985.db     Document Type: Article

References (17)

1. Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993;192:553-560.
2. Ichiki Y, Kitamura K, Kangawa K, et al. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 1994;338:6-10.
3. Sakata J, Shimokubo T, Kitamura K, et al. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett. 1994;352:105-108.
4. Ishiyama Y, Kitamura K, Ichiki Y, et al. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol. 1993;241:271-273.
5. Nakamura M, Yoshida H, Makita S, et al. Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Circulation. 1997;95:1214-1221.
6. Nagaya N, Satoh T, Nishikimi T, et al. Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation. 2000;101:498-503.
7. Nagaya N, Goto Y, Satoh T, et al. Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction. J Cardiovasc Pharmacol. 2002;39:754-760.
8. Nagaya N, Nishikimi T, Uematsu M, et al. Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension. Heart. 2000;84:653-658.
9. Nagaya N, Kyotani S, Uematsu M, et al. Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension. Circulation. 2004;109:351-356.
10. Sabates BL, Pigott JD, Choe EU, et al. Adrenomedullin mediates coronary vasodilation through adenosine receptors and KATP channels. J Surg Res. 1997;67:163-168.
11. Nagaya N, Kangawa K. Adrenomedullin in the treatment of pulmonary hypertension. Peptides. 2004;25:2013-2018.
12. Nishimatsu H, Suzuki E, Nagata D, et al. Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta. Circ Res. 2001;89:63-70.
13. Nossaman BD, Feng CJ, Kaye AD, et al. Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats. Am J Physiol. 1996;270:L782-L789.
14. Takahashi Y, de Vroomen M, Gournay V, et al. Mechanisms of adrenomedullin-induced increase of pulmonary blood flow in fetal sheep. Pediatr Res. 1999;45:276-281.
15. De Matteo R, May CN. Direct coronary vasodilator action of adrenomedullin is mediated by nitric oxide. Br J Pharmacol. 2003;140:1414-1420.
16. Teragawa H, Kato M, Yamagata T, et al. Magnesium causes nitric oxide independent coronary artery vasodilation in humans. Heart. 2001;86:212-216.
17. Teragawa H, Fukuda Y, Matsuda K, et al. Relation between C reactive protein concentrations and coronary microvascular endothelial function. Heart. 2004;90:750-754.